Form 4: Tandem Diabetes Officer Vests Equity

Tandem Diabetes Care's EVP & Chief Administrative Officer, Susan Morrison, acquired common stock through RSU vesting and disposed of shares for tax obligations.

Summary

• Susan Morrison, EVP & Chief Administrative Officer, acquired 1,503 shares of Tandem Diabetes Care common stock on August 15, 2025, through the vesting of restricted stock units (RSUs) awarded on May 25, 2023.
• Concurrently, 430 shares were disposed of at $10.82 per share to satisfy tax withholding requirements related to the RSU vesting.
• An additional 1,097 shares of common stock were acquired on August 15, 2025, from the vesting of RSUs awarded on May 23, 2024.
• Another 314 shares were disposed of at $10.82 per share for tax withholding purposes related to this second RSU vesting.
• Following these transactions, Susan Morrison directly beneficially owns 39,062 shares of Tandem Diabetes Care common stock.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as an executive is increasing their direct equity ownership through RSU vesting, indicating continued alignment with shareholder interests. The share disposal is solely for tax purposes, which is a standard and expected part of RSU vesting.

Positives

• Executive Susan Morrison continues to increase direct beneficial ownership of common stock through RSU vesting, aligning her interests with shareholders.
• The vesting of restricted stock units indicates the achievement of performance or tenure milestones.

Negatives

• A portion of vested shares (744 shares total) were disposed of to cover tax withholding obligations, which is a common practice but reduces the net shares acquired.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Increased alignment of executive interests with shareholders due to continued equity ownership.
• Employees: The RSU vesting demonstrates the company's commitment to its long-term incentive plan for executives.

Key Dates

Recommendation

This Form 4 filing details routine RSU vesting and tax-related share disposals by an executive. Such transactions are standard and do not typically indicate a change in the company's fundamental prospects or warrant a strong buy/sell recommendation. The executive's continued equity ownership is a positive for alignment, but the filing itself does not provide new information to alter an investment thesis.

Keywords

Tandem Diabetes Care, TNDM, SEC Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Executive Compensation, Susan Morrison, Equity Ownership, Diabetes Care